Georgiamune reportedly selling preclinical cancer drug to Menarini in deal worth up to $1.1B

Georgiamune is reportedly selling a preclinical cancer drug to Italy's Menarini in a deal worth up to $1.1 billion, according to an exclusive report.

Detected & updated continuously · Source: Nebula